# Vapocoolant Analgesia for Breast Lymphoscintigraphy

> **NCT05744557** · NA · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** num Vapocoolant

## Key facts

- **NCT ID:** NCT05744557
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-05-13
- **Final completion:** 2025-05-13
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** \<75% accrued participants
- **Last updated:** 2025-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05744557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05744557, "Vapocoolant Analgesia for Breast Lymphoscintigraphy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05744557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*